It contains as an active ingredient an agonist for at least one receptor selected from adiponectin receptor 1 (PAQR1), adiponectin receptor 2 (PAQR2), adiponectin receptor 3 (PAQR3), and adiponectin receptor 4 (PAQR4). Provided are a chondrocyte proliferation promoting agent, a chondrocyte proliferation promoting method using the chondrocyte proliferation promoting agent, and a screening method for a chondrocyte proliferation promoting agent.
展开▼